¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Central portion of breast"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • central gray
    Áß½Éȸ»öÁú
  • central hearing loss
    ÁßÃßû·Â¼Ò½Ç, ÁßÃß³­Ã»
  • central hemorrhagic necrosis
    Áß½ÉÃâÇ÷±«»ç
  • central incisor
    Á߽ɾմÏ, ÁßÀýÄ¡
  • central insertion
    Á߽ɺÎÂø
  • central karyosome
    Áß½ÉÇÙ¼Òü
  • central lateral nucleus
    °¡ÂÊÁß½ÉÇÙ, Á߽ɿÜÃøÇÙ
  • central lymphoid organ
    ÁßÃ߸²ÇÁ±â°ü
  • central medial nucleus
    ¾ÈÂÊÁß½ÉÇÙ, Á߽ɳ»ÃøÇÙ
  • central necrosis
    Á߽ɱ«»ç
  • central nervous system
    ÁßÃ߽Űæ°èÅë, ÁßÃ߽Űæ°è
  • central neurogenic hyperpnea
    ÁßÃ߽Űæ°ú´ÙÈ£Èí
  • central nucleus
    Áß½ÉÇÙ
  • central pain
    ÁßÃßÅëÁõ, ÁßÃ߽ŰæÅë
  • central pain syndrome
    ÁßÃßÅëÁõÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • central resection
    Áß¾ÓÀýÁ¦(¼ú)
  • central retinitis
    Á߽ɸÁ¸·¿°
  • central scotoma
    Á߽ɾÏÁ¡
  • central sulcus
    Á߽ɰí¶û
  • central suppression
    Á߽ɾïÁ¦
  • central synapse
    ÁßÃß¿¬Á¢
  • central tendon
    Á߽ɳÎÈûÁÙ
  • central vision
    Á߽ɽ÷Â, Á߽ɽð¢
  • central zone
    Á߽ɱ¸¿ª
  • central artery syndrome
    Á߽ɵ¿¸ÆÁõÈıº
  • central cord syndrome
    Áß½Éô¼öÁõÈıº
  • central core disease
    Áß½ÉÇÙº´
  • central disciform retinopathy
    Á߽ɿø¹Ý¸Á¸·º´Áõ
  • central echo complex
    Á߽ɹÝÇ⺹ÇÕü, Á߽ɸ޾Ƹ®º¹ÇÕü
  • central excitatory state
    ÁßÃßÈïºÐ»óÅÂ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • breast/ovarian familial cancer syndrome
    À¯¹æ/³­¼Ò °¡Á·¼º ¾ÏÁõÈıº
  • caked breast
    ÄÉÀÌÅ©À¯¹æ ¡ì»ê¿åÀ¯¼±¿°ÀÇ ¼Ó¸í¡í.
  • feeding breast
    ¸ðÀ¯¿µ¾ç.
  • funnel breast
    ´©µÎÈä(שÔàýØ).
  • gargantuan breast
    ºñ´ë¼º À¯¹æ(ºñ´ë¼ºÀ¯¹æ).
  • gargantuan breast
    ºñ´ë¼º À¯¹æ(ÝþÓÞàõêáÛ®).
  • gathered breast
    À¯¹æ³ó¾ç(À¯¹æ³ó¾ç).
  • hysterical breast
    È÷½ºÅ׸®¼º À¯¹æ(½Å°æÅë).
  • interventional breast ultrasound
    ÁßÀçÀû À¯¹æÃÊÀ½ÆÄ°Ë»ç
  • irritable breast
    °ú¹Î(¼º) À¯¹æ.
  • male breast
    ³²¼ºÁ¥
  • pigeon breast
    ºñµÑ±â°¡½¿.
  • pigeon breast
    ºñµÑ±â°¡½¿
  • pigeon-breast deformity
    ºñµÑ±â°¡½¿¸ð¾ç(Ù¼åÆ)ÀÇ º¯Çü(ܨû¡)
  • sclerosing adenosis,of breast
    À¯¹æÀÇ(êáÛ®¡­)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Central glial cell
    ÁßÃ߾Ʊ³¼¼Æ÷
    [¿¾ ¿ë¾î] Á߽ɽŰ汳¼¼Æ÷
  • Glial cell of central nervous system
    ÁßÃ߾Ʊ³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁßÃß±³¼¼Æ÷
  • Short central artery
    ªÀºÁ߽ɵ¿¸Æ
    [¿¾ ¿ë¾î] ´ÜÁ߽ɵ¿¸Æ
  • (Lymphatic ring of cardiac portion)
    (µé¹®¸²ÇÁÀý°í¸®)
    [¿¾ ¿ë¾î] ºÐ¹®ÀÓÆÄÀý°í¸®
  • Vaginal portion of cervix
    (Àڱøñ)ÁúºÎÀ§
    [¿¾ ¿ë¾î] (Àڱðæ)ÁúºÎ
  • Transverse portion
    °¡·Îµ¹±âºÎºÐ
    [¿¾ ¿ë¾î] Ⱦµ¹±âºÎ
  • Transverse portion
    °¡·ÎºÎºÐ
    [¿¾ ¿ë¾î] ȾºÎ
  • Lateral portion
    °¡ÂʺκÐ
    [¿¾ ¿ë¾î] ¿ÜÃøÁö
  • Atlatic portion
    °í¸®»ÀºÎºÐ
    [¿¾ ¿ë¾î] ȯÃߺÎ
  • Precommunicating portion
    ±³ÅëÀÌÀüºÎºÐ
    [¿¾ ¿ë¾î] ±³ÅëÀüºÎ
  • Postcommunicating portion
    ±³ÅëÀÌÈĺκÐ
    [¿¾ ¿ë¾î] ±³ÅëÈĺÎ
  • Postcommunicating portion
    ±³ÅëÀÌÈĺκР[³úµéº¸ÁÖÀ§µ¿¸Æ]
    [¿¾ ¿ë¾î] ±³ÅëÈĺÎ
  • Intersegmental portion
    ±¸¿ª»çÀ̺κÐ
    [¿¾ ¿ë¾î] ±¸°£Áö
  • Intrasegmental portion
    ±¸¿ª¼ÓºÎºÐ
    [¿¾ ¿ë¾î] ±¸³»Áö
  • Alveolar terminal portion
    ²Ê¸®Á¾¸»ºÎÀ§
    [¿¾ ¿ë¾î] Æ÷»óÁ¾¸»ºÎ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
BCDDP Breast Cancer Detection Demonstration Project
BCEI breast cancer estrogen-inducible
BCF basophil chemotactic factor; bioconcentration factor; breast cyst fluid
BCFP breast cyst fluid protein
BCPT breast cancer prevention trial
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
BF Breast feeding
CBE Clinical breast examination
DBCG Danish Breast Cancer Co-operative Group
IBR Immediate breast reconstruction
IBC Inflammatory breast cancer
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • central dimple
    Á߽ɼº ¼Ò¿Í
  • central dogma
    Á᫐ ±³Á¶
  • central end
    Á᫐ ¸»´Ü
  • central excitatory state
    ÁßÃß ÈïºÐ »óÅÂ
  • central fossa
    Á᫐ ¿Í
    ´ë±¸Ä¡ ±³ÇÕ¸éÀÇ Áß¾Ó ºÎÀ§¿¡ ÀÖ´Â ¿øÇü ¸ð¾çÀÇ ÇÔ¸ôºÎ¸¦ ¸»Çϸç Á᫐ ±³Çսà ÀÌ ºÎÀ§´Â ´ëÇÕÄ¡ÀÇ ±â´É ±³µÎ¿Í ¸¸³ª°Ô µÈ´Ù.
  • central fovea
    Á᫐ ¿À¸ñ
  • central giant cell
    °ñ³» °Å´ë ¼¼Æ÷
  • central giant cell tumor
    Á߽ɼº °Å´ë ¼¼Æ÷ ¾ÏÁ¾
  • central groove
    Á᫐ ±¸
    ±¸Ä¡¿¡ À־ ¼³Ãø ±³µÎ¿Í ÇùÃø ±³µÎ »çÀÌ¿¡ Çü¼ºµÈ ±¸·Î½á ±Ù½É ¼Ò¿Í¿¡¼­ Á᫐ ¼Ò¿Í, ¿ø½É ¼Ò¿Í¸¦ ¿¬°áÇÏ°Ô µÇ¸ç ±³ÇÕ¸éÀ» ÇùÃø ¹ÝºÎ¿Í ¼³Ãø ¹ÝºÎ·Î ³ª´«´Ù.
  • central heating
    Áß¾Ó ³­¹æ
  • central hemorrhagic necrosis
    ÃâÇ÷¼º Á᫐ Á¤¾× ±«»ç
  • central incisor
    ÁßÀýÄ¡
    À½½ÄÀ» Àý´ÜÇϴµ¥ ¾²ÀÌ´Â ÀýÄ¡ Áß Á¤Áß¼±¿¡¼­ ù ¹øÂ°¿¡ À§Ä¡Çϰí Á¿ì·Î 1°³¾¿ ÀÖÀ¸¸ç ÀýÄ¡ Áß °¡Àå Å©°í ±Ù¿ø½É°æÀÌ ¼ø¼³°æº¸´Ù Å« Ä¡¾ÆÀÌ´Ù. ¼ø¸é¿¡¼­ º¸¾ÒÀ» ¶§ ±Ù½É¿¬Àº Á÷¼±ÀûÀÌ°í ±æ¸ç ¿ø½É¿¬Àº °î¼±ÀûÀ̰í ª´Ù. ±×¸®°í Áß¾Ó¼ø¿¬ À¶¼±À» Áß½ÉÀ¸·Î ±Ù½É ¹ÝºÎ´Â ¿ø½É ¹ÝºÎº¸´Ù Å©´Ù. Àý´Ü¿¬Àº ±Ù½É¿¡¼­ ¿ø½ÉÀ¸·Î Ä¡°æÃøÀ» ÇâÇØ °æ»çÁ® ÀÖ°í ¼³¸é °áÀýÀÇ Á¤Á¡ÀÌ ¾à°£ ¿ø½ÉÃø¿¡ À§Ä¡ÇÑ´Ù. ±Ù½É¿¬Àº ¿ø½É¿¬º¸´Ù ³Ð°í ÆòźÇϸç Ä¡°æ¼±ÀÇ ¸¸°îµµµµ ´õ Å©´Ù. Ä¡¾ÆÀÇ 3»ó¡ÀÎ ¿ì°¢ »ó¡, ¸¸°î »ó¡, Ä¡±Ù »ó¡ÀÌ Àß ³ªÅ¸³ª¸ç ´Ü±ÙÄ¡À̰í ÀüüÀûÀ¸·Î ±½Àº ¿øÃßÇüÀ» Çϰí ÀÖ´Ù.
  • central inhibitory connection
    ÁßÃß ¾ïÁ¦ ¿¬°á
  • central insertion
    Á᫐ ºÎÂø
  • central lateral
    Áß½É Ãø¹æ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
stellate breast lesions <radiology> Scirrhous carcinoma (infiltrating ductal carcinoma), small (baby) scirrhous carcinoma, sclerosing ductal hyperplasia, traumatic fat necrosis, hyalinised fibroadenoma
(12 Dec 1998)
supernumerary breast A milk-secreting gland located elsewhere than at the normal place on the chest and existing in addition to the two usual mammae.
Synonym: mamma accessoria, accessory breast, supernumerary mamma.
(05 Mar 2000)
suspensory ligaments of breast Well developed retinacula cutis that extend from the fibrous stroma of the mammary gland to the overlying skin.
Synonym: ligamenta suspensoria mammae, Cooper's ligaments, suspensory ligaments of Cooper.
(05 Mar 2000)
diameter at breast height The width of a plant stem (for example, tree trunk) as measured at 4.5 feet above the ground surface.
(09 Oct 1997)
irritable breast Swelling and induration of the breast, not due to a neoplasm, and usually of comparatively brief duration.
(05 Mar 2000)
thermography-breast A special infrared study which measures the skin temperature across the breasts. Used in the evaluation of breast abscess, breast cancer or another inflammatory process. This test is being replaced by breast ultrasound
(27 Sep 1997)
early stage breast cancer <oncology> Cancer is confined to the breast and has not spread to other sites in the body.
(16 Dec 1997)
familial breast cancer <oncology> A number of factors have been identified that increase the risk of breast cancer. One of the strongest of these risk factors is the history of breast cancer in a relative. About15-20% of women with breast cancer have such a family history of the disease, clearly reflecting the participation of inherited (genetic) components in the development of some breast cancers. Dominant breast cancer suceptibility genes, including BRCA1 and BRCA2, appear responsible for about 5% of all breast cancer. See related entries to: Breast cancer susceptibility genes; BRCA1; BRCA2.
There are 2 genes; BRCA1 and BRCA2 which are susceptibility genes for breast cancer. They are inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the li-fraumeni syndrome, cowden disease, muir-torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. However, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered.
(12 Dec 1998)
ultrasound of the breast <investigation> A test which uses ultrasonic waves to scan the breast. Used to evaluate fibrocystic breast disease, breast implants or breast masses.
(27 Sep 1997)
feeding, breast The ability of the breast to produce milk diminishes soon after childbirth without the stimulation of breastfeeding. Immunity factors in breast milk can help the baby to fight off infections. Breast milk contains vitamins, minerals, and enzymes which aid the baby's digestion. Breast and formula feeding can be used together.
(12 Dec 1998)
fibrocystic condition of the breast A benign disease common in women of the third, fourth, and fifth decades characterised by formation, in one or both breasts, of small cysts containing fluid which may appear as blue dome cysts; associated with stromal fibrosis and with variable degrees of intraductal epithelial hyperplasia and sclerosing adenosis.
Synonym: cystic hyperplasia of the breast.
(05 Mar 2000)
fibrocystic disease of breast A chronic disorder comprising three variants which range from lesions consisting primarily of an overgrowth of fibrous tissue to those characterised by dominance of the proliferation of the epithelial parenchyma to a form of dysplasia characterised by both stromal and epithelial hyperplasia with the formation of cysts.
(12 Dec 1998)
large breast lesions <radiology> Breast masses greater than 5 cm, lucent: lipoma, mixed lucent/opaque: fibro-adeno-lipoma, low-density opaque: giant fibroadenoma, cyst, cystosarcoma phylloides, mucinous carcinoma, high-density opaque (large and dense)
(12 Dec 1998)
large, dense breast lesions <radiology> Carcinoma, sarcoma, cystosarcoma phylloides, cyst, abscess, lymph nodes (lymphoma, leukaemia, metastasis)
(12 Dec 1998)
funnel breast Caved-in chest. Usually an unimportant isolated finding evident at birth. (Funnel chest can occasionally be part of a connective tissue disorder such as Marfan syndrome).
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á